Re:Goldman Sachs questions whether curing patients is a sust...
by tootie on Friday April 13, 2018 @08:55AM
(#16829495)
They earn less money off of a cure than a palliative, but not everything the health care industry does is treating disease and the health care industry isn't one company. If one company owns the patent on a popular AIDS treatment, that would not at all stop a competitor from offering a cure if they had one. It's not company A's best interest, but it is in company B's.
[ Parent
| on HN ]
There are no comments on this comment yet.